GENFIT S.A.

4.62-0.0100-0.22%Vol 25.76K1Y Perf -73.42%
Apr 13th, 2021 15:59 DELAYED
BID4.49 ASK4.63
Open4.59 Previous Close4.63
Pre-Market- After-Market-
 - -  - -%
Target Price
10.60 
Analyst Rating
Moderate Buy 2.33
Potential %
129.44 
Finscreener Ranking
★★+     48.10
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
+     36.16
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★+     51.57
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap179.53M 
Earnings Rating
Price Range Ratio 52W %
5.25 
Earnings Date
-

Today's Price Range

4.474.62

52W Range

3.6322.48

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-0.22%
1 Month
-4.74%
3 Months
-16.46%
6 Months
5.24%
1 Year
-73.42%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
GNFT4.62-0.0100-0.22
AAPL134.433.19002.43
GOOG2 267.2712.48000.55
MSFT258.312.40000.94
XOM55.710.21000.38
WFC39.79-0.9800-2.40
JNJ159.48-2.1600-1.34
FB309.76-1.7800-0.57
GE13.44-0.1500-1.10
JPM154.09-1.8600-1.19
Financial StrengthValueIndustryS&P 500US Markets
5.90
5.90
0.85
5.88
-3.00
Leverage Ratio -12.30
ProfitabilityValueIndustryS&P 500US Markets
82.60
-180.40
-169.20
-15 119.60
-45.44
RevenueValueIndustryS&P 500US Markets
927.68K
0.02
275.07
42.95
Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
9/2020 QR-0.300.00-
12/2020 QR-0.240.00-
12/2021 FY-1.98-15.12Negative
12/2022 FY-1.13-0.89Negative
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %29.60
Volume Overview
Volume25.76K
Shares Outstanding38.86M
Trades Count172
Dollar Volume562.23K
Avg. Volume237.49K
Avg. Weekly Volume26.47K
Avg. Monthly Volume27.76K
Avg. Quarterly Volume266.66K

GENFIT S.A. (NASDAQ: GNFT) stock closed at 4.62 per share at the end of the most recent trading day (a -0.22% change compared to the prior day closing price) with a volume of 25.76K shares and market capitalization of 179.53M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 201 people. GENFIT S.A. CEO is Pascal Prigent.

The one-year performance of GENFIT S.A. stock is -73.42%, while year-to-date (YTD) performance is -3.75%. GNFT stock has a five-year performance of %. Its 52-week range is between 3.63 and 22.48, which gives GNFT stock a 52-week price range ratio of 5.25%

GENFIT S.A. currently has a PE ratio of -1.50, a price-to-book (PB) ratio of 5.16, a price-to-sale (PS) ratio of 209.25, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -39.81%, a ROC of -23.94% and a ROE of -298.13%. The company’s profit margin is -45.44%, its EBITDA margin is -169.20%, and its revenue ttm is $927.68 Thousand , which makes it $0.02 revenue per share.

Of the last four earnings reports from GENFIT S.A., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. GENFIT S.A.’s next earnings report date is -.

The consensus rating of Wall Street analysts for GENFIT S.A. is Moderate Buy (2.33), with a target price of $10.6, which is +129.44% compared to the current price. The earnings rating for GENFIT S.A. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

GENFIT S.A. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

GENFIT S.A. has a Sell technical analysis rating based on Technical Indicators (ADX : 13.24, ATR14 : 0.30, CCI20 : -69.00, Chaikin Money Flow : 0.16, MACD : -0.17, Money Flow Index : 35.53, ROC : -0.86, RSI : 43.65, STOCH (14,3) : 53.57, STOCH RSI : 0.94, UO : 63.46, Williams %R : -46.43), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of GENFIT S.A. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (33.33 %)
2 (33.33 %)
5 (83.33 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
4 (66.67 %)
4 (66.67 %)
1 (16.67 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.33
Moderate Buy
2.33
Strong Buy
1.33

GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. The company conducts clinical trials in a variety of European and North American countries when advancing through stages of development.

CEO: Pascal Prigent

Telephone: +33 320164000

Address: Parc Eurasante, Loos 59120, , FR

Number of employees: 201

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

69%31%

Bearish Bullish

42%58%

Bearish Bullish

65%35%

News

Stocktwits